Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2014 1
2018 3
2019 3
2020 7
2021 12
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer: Biology, biomarkers, and treatments.
Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E, Farahmand L. Barzaman K, et al. Among authors: kazemi mh. Int Immunopharmacol. 2020 Jul;84:106535. doi: 10.1016/j.intimp.2020.106535. Epub 2020 Apr 29. Int Immunopharmacol. 2020. PMID: 32361569 Review.
Breast cancer immunotherapy: Current and novel approaches.
Barzaman K, Moradi-Kalbolandi S, Hosseinzadeh A, Kazemi MH, Khorramdelazad H, Safari E, Farahmand L. Barzaman K, et al. Among authors: kazemi mh. Int Immunopharmacol. 2021 Sep;98:107886. doi: 10.1016/j.intimp.2021.107886. Epub 2021 Jun 19. Int Immunopharmacol. 2021. PMID: 34153663 Review.
Oncolytic virotherapy in hematopoietic stem cell transplantation.
Kazemi MH, Kuhestani Dehaghi B, Roshandel E, Parkhideh S, Mehdizadeh M, Salimi M, Hajifathali A, Hamidpour M. Kazemi MH, et al. Hum Immunol. 2021 Sep;82(9):640-648. doi: 10.1016/j.humimm.2021.05.007. Epub 2021 Jun 9. Hum Immunol. 2021. PMID: 34119352 Review.
CD73 as a potential opportunity for cancer immunotherapy.
Ghalamfarsa G, Kazemi MH, Raoofi Mohseni S, Masjedi A, Hojjat-Farsangi M, Azizi G, Yousefi M, Jadidi-Niaragh F. Ghalamfarsa G, et al. Among authors: kazemi mh. Expert Opin Ther Targets. 2019 Feb;23(2):127-142. doi: 10.1080/14728222.2019.1559829. Epub 2018 Dec 26. Expert Opin Ther Targets. 2019. PMID: 30556751 Review.
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
Sadri M, Najafi A, Rahimi A, Behranvand N, Hossein Kazemi M, Khorramdelazad H, Falak R. Sadri M, et al. Among authors: hossein kazemi m. Int Immunopharmacol. 2023 Sep;122:110470. doi: 10.1016/j.intimp.2023.110470. Epub 2023 Jul 9. Int Immunopharmacol. 2023. PMID: 37433246 Review.
Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019.
Khorramdelazad H, Kazemi MH, Azimi M, Aghamajidi A, Mehrabadi AZ, Shahba F, Aghamohammadi N, Falak R, Faraji F, Jafari R. Khorramdelazad H, et al. Among authors: kazemi mh. Eur J Pharmacol. 2022 Jul 15;927:175051. doi: 10.1016/j.ejphar.2022.175051. Epub 2022 May 23. Eur J Pharmacol. 2022. PMID: 35618037 Free PMC article. Review.
34 results